Zentiva
| Industry | Pharmaceuticals |
|---|---|
| Headquarters | Prague, Czech Republic |
| Parent | Sanofi |
| Website | www.zentiva.com |
Zentiva N.V. is an international pharmaceutical company focused on developing, manufacturing and marketing modern generic pharmaceutical products. Since 2009 Zentiva is the generic drug arm of Sanofi. Its Romanian subsidiary, Zentiva SA is traded on Bucharest stock exchange (BVB: SCD).
History of Zentiva
- The Black eagle, "U černého orla" pharmacy in Prague is purchased by Benjamin and Karel Fragner in 1857.
- First factory at Dolní Měcholupy in 1930
- Nationalization by the Czech government in 1946
- Generic strategy in 1998
- Acquisition of Leciva Slovakofarma in 2003, the main pharmaceutical company of Slovakia[1]
- Acquisition of Sicomed SA Bucharest (nowadays Zentiva SA) in 2005, the leading generics company in Romania
Generic strategy of Sanofi
The Company addresses a wide range of therapeutic areas but has a particular focus on cardiovascular disorders, inflammatory conditions, pain, infections and diseases of the central nervous system and the gastrointestinal and urology fields.
External links
References
- ↑ "Archived copy" (PDF). Archived from the original (PDF) on April 25, 2012. Retrieved November 12, 2011.
This article is issued from Wikipedia - version of the 9/10/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.